<?xml version="1.0" encoding="UTF-8"?>
<p id="par0320">An urgent response to the brisk expansion of COVID-19 has been evoked throughout scientific communities in order to develop an effective vaccine. Rapid genome sequencing and potential molecular targets have been identified, and more than 20 vaccines are currently under investigation. Some of these vaccines have shown effectiveness in preclinical studies, while still others are already in phase I clinical trials [
 <xref rid="bib0470" ref-type="bibr">[94]</xref>, 
 <xref rid="bib0475" ref-type="bibr">[95]</xref>, 
 <xref rid="bib0480" ref-type="bibr">[96]</xref>].
</p>
